What the reform is about
We are modernising Part B in line with the changes to the rest of the Prescribed List.
How we will achieve this
There are two initiatives to modernise Part B:
- Revise the classification structure;
- Introduce health technology assessment for human tissue products.
We have and will continue to work with relevant stakeholders to progress this reform measure.
Timeline
We publish a high level summary which was prepared by the department in December 2024.
This document does not provide the department’s analysis of the stakeholder submissions but rather provides a high level summary of the feedback received and our response to each of the 10 recommendations on the PricewaterhouseCoopers’ final report.
This summary of feedback should be read in conjunction with stakeholder feedback submissions that have also been published.
We have also published individual submissions to our consultation on the report.
Reforms to the Prescribed List Part B – Analysis of stakeholder feedback
| Date | Activity |
|---|---|
| August 2023 – October 2023 | Consulted on the recommendations in the PwC final report |
| August 2023 | Published initial departmental response to PwC recommendations in the final report |
| May 2023 | PwC delivered a final report, including 10 key recommendations to support the proposed reforms to Part B of the PL |
| February 2023 – March 2023 | PwC consulted with key Part B stakeholders via two workshops |
| December 2022 | Engaged PwC to review Consultation Paper 2(a) and stakeholder feedback |
| January 2022 – March 2022 | Consulted on ways to modernise Part B Consultation Paper 2(a) – Modernisation of Part B of the Prostheses List |